TH1 cells have also been reported to reshape the tumor-associated myeloid cell network, promoting interferon-activated antigen presentation and iNOS-expressing tumoricidal effector phenotypes, which together indirectly eradicates interferon-unresponsive and MHC-deficient tumors (48). The gene discussed is HLA-C; the disease is neoplasm.